H.C. Wainwright raised the firm’s price target on ASP Isotopes to $5.50 from $5.25 and keeps a Buy rating on the shares following the Q4 report. The analyst expects the company to continue generating revenue and says management has already successfully de-risked its operations during the year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPI:
- ASP Isotopes issues letter to shareholders
- ASP Isotopes Issues Letter to Stockholders
- ASP Isotopes enters warrant inducement transaction for $5.5M in gross proceeds
- ASP Isotopes Inc. Enters Into Warrant Inducement Transaction for Approximately $5.5 Million in Gross Proceeds
- ASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels